• Effect of P on Pb and As relative bioavailability and bioaccessibility were studied.
Introduction
Due to extensive economic development in recent years, China faces the challenges of soil contamination with heavy metals [1] . Anthropogenic activities such as mining and smelting have elevated Pb and As concentrations in soils [2, 3] . Recent nationwide surveys in China show that 13.3% of soil samples are contaminated by heavy metals, of which As and Pb rank the 3rd and 5th places [4] . Arsenic is toxic and carcinogenic while Pb is a neurotoxin, both posing health risks to humans [5] . Soil ingestion via hand-to-mouth activities is an important pathway for children exposure to Pb and As [6] . However, following ingestion, only a fraction of As and Pb in contaminated soil can be absorbed by the organisms, i.e., the bioavailable fraction [7] . Therefore, effective strategies are needed to decrease their exposure via incidental soil ingestion.
Phosphorus (P) amendment has been used to lower Pb relative bioavailability (RBA, relative to soluble Pb acetate) in contaminated soils [3, 8] . Lead immobilization is via P dissolution and precipitation of stable Pb-P minerals such as pyromorphite [9, 10] . Juhasz et al. [3] showed that in situ formation of pyromorphite in contaminated soils is not required to reduce their Pb-RBA based on an in vivo mouse bioassay. Following amendment with phosphoric acid (PA) or rock phosphate at P:Pb molar ratio of 5:1, Pb-RBA in 3 soils are decreased compared to control soils. However, similar decrease is also observed in control soil following a sequential gavage of soil and PA or rock phosphate. In this case, in vivo formation of insoluble Pb phosphates after the sequential gavage accounts for the reduction in Pb-RBA [3] .
However, there is a lack of report on the influences of P amendment on As-RBA in contaminated soils. As a chemical analog, P may increase soil As mobility, making it more soluble in gastrointestinal (GI) fluids, thereby increases As bioaccessibility [11] . However, dissolved P may also inhibit As absorption across the GI tract. This is because arsenate may share the same transporter in small intestinal phase with phosphate, i.e., P transporter [12] . As such, the impact of P amendment on As-RBA may not be easily concluded. In other words, the possibility of increased As-BRA due to increasing As solubility in the GI fluid and decreased As-BRA due to inhibition of As absorption both exists. However, there are limited studies focusing on the impact of P amendment on As-RBA in contaminated soils.
Animal models including swine and mice have been used to determine the RBA of As and Pb in contaminated soils [13, 14] . However, due to their cost and time concern, they are inappropriate to determine metal RBA on a large scale [8] . In vitro and in vivo correlations (IVIVCs) have been used to test the ability of in vitro bioaccessibility assays as surrogate of in vivo assays to predict Pband As-RBA [15] [16] [17] [18] . However, these in vitro assays are based on contaminated soils, their suitability to assess the influence of P amendment on metal-RBA is unclear [8] . Based on P-amended soils whose Pb-RBA has been determined using an in vivo mouse bioassay [3] , Juhasz et al. [19] measured Pb bioaccessibility using five in vitro assays. They showed that comparing the effect of P amendment on Pb-RBA and bioaccessibility provided strong IVIVCs for SBRC (R 2 = 0.83) and IVG (R 2 = 0.89) based on intestinal phase, indicating Pb-RBA in P-amended soils can be predicted using in vitro assays. However, the developed model lacks robustness due to small dataset and limited soils [19] . In addition, there is a lack of comparison of As-RBA and As bioaccessibility in P-amended soils, which warrants further investigation.
In the current study, 5 soils co-contaminated with Pb and As were amended with phosphoric acid (PA) to study its influences on Pb-and As-RBA and bioaccessibility. A newly-developed mouse kidney model and 4 in vitro assays including UBM (unified BARGE), SBRC (Solubility Bioaccessibility Research Consortium), IVG (in vitro gastrointestinal), and PBET (physiologically based extraction test) were used to determine Pb-and As-RBA and bioaccessibility in soils. In addition, the ability of in vitro assays to predict As-and Pb-RBA in PA-amended soils was assessed.
Materials and methods

Contaminated soils
Five soils that were co-contaminated with Pb and As were collected from different locations in China (Table 1) . Soil A, C, D, and E were contaminated by smelting activity while soil B by mining activity. After being dried, the soils were first sieved to <2 mm using a nylon sieve, and then sieved to <250 m. Concentrated HNO 3 and 30% H 2 O 2 were used to digest soils following USEPA Method 3050B. Amorphous Fe, Al, and Mn oxides (Fe AM , Al AM , and Mn AM ) were extracted using acid ammonium oxalate [20] . Soil pH was determined in water extract (1:5 soil: solution) after shaking for 2 h. Total organic carbon (TOC) content was determined as loss on ignition at 900 • C using an element analyzer (vario TOC select, Elementar, Germany) after removing carbonate carbon with HCl. A laser diffractometer (Mastersizer 2000, Malvern, UK) was used to obtain soil clay content.
Lead and As concentrations in solutions were determined using inductively-coupled plasma mass spectrometry (ICP-MS, Nex-IONTM300X, Perkin Elmer, USA). Iron, Al, Mn, Ca and P in the digests or extracts were quantified using an inductively coupled plasma optical emission spectrometry (ICP-OES, Optima 5300, PerkinElmer SCIEX, USA). A certified reference material (D056-540) from Environmental Resource Associates was included for quality assurance/quality (QA/QC) control of digestion process. The recoveries for Pb, As, and Ca were 95.7 ± 6.41, 97.5 ± 5.82, and 99.3 ± 2.14% (n = 3).
Soil amendment with phosphate
Phosphate is effective in immobilizing Pb in contaminated soils [21] . It reacts with soil Pb to form insoluble minerals such as pyromorphite, reducing Pb bioavailability to humans [9, 22] . To optimize Pb immobilization, lower soil pH has been recommended to provide more Pb to react with P to form Pb-P minerals [21] , so phosphoric acid (P) was used in this study. Phosphoric acid was diluted with Milli-Q water and added to 150 g soils in plastic bottles to achieve 5 g P kg −1 soil at 100% water holding capacity following Juhasz et al. [3, 23, 24] . A pestle was used to mix the wet soil about 10 min until it was homogenous. Bottles were covered with perforated plastic film, and the soil was aged for 2 weeks at room temperature, which is sufficient for Pb and P to form Pb-phosphate minerals [3] . During aging, all samples were remixed every 2 d following the above mentioned procedure and moisture was maintained through gravimetric determination. At the end of 2 weeks, soil pH was measured and quicklime was added to soils to maintain original soil pH as needed. The soils were then aged for additional 14 d prior to being freeze-dried.
Pb and As relative bioavailability in contaminated soils
Female Balb/c mice with body weight (bw) of 18-22 g were used to determine Pb and As bioavailability in PA-amended soils. Animal care and experimental protocol were approved by the Institutional Animal Care Committee at Nanjing University. Mice were acclimatized in metabolic cages for 7 d with 12/12 light/dark cycles. During this period, Milli-Q water and rodent diet were supplied ad libitum.
At the end of acclimation, mice were fasted overnight and then weighted before being randomly assigned into plastic cages. Fasted animals were used to represent a "worst-case scenario" for contaminant exposure. To minimize possible effect of feed (containing 0.9% P) on Pb and As-RBA determination [25] , soil exposure and mouse Table 1 Selected properties of 5 contaminated soils (< 250 m particle size; AM = amorphous).
Characteristics
Soil Mice receiving 0.5 mL of Milli-Q water were used as control. Following gavage, mice were provided with water and fasted for additional 8 h followed by diet consumption during 18:00-22:00. After feeding, mice were fasted overnight again and prepared for exposure experiment next day. Using the separated dosing of soil and diet feeding, the possible influence of high P in the mouse diet on Pb and As-RBA determination was avoided. It is reported that repeated steady state soil dose to mice improves the repeatability of measured RBA, while single gavage dose exposure usually results in RBA with relative standard deviation >20% [26, 27] . Therefore, to improve the repeatability of RBA, a new method based on single daily gavage over 10-d period was developed. After 10-d exposure, mice were fasted overnight, weighed, and sacrificed to collect kidney samples. The kidneys were immediately stored at −80 • C before being freeze-dried. Lead and As concentrations in the kidneys were determined using ICP-MS following digestion using USEPA Method 3050B.
Before determining Pb and As-RBA in soils, linear response curves of Pb and As accumulation in mouse kidneys to Pb and As dose level was established (Fig. 1) . Then Pb and As-RBA in soils were calculated as the ratio of dose normalized Pb or As concentration in the kidneys following soil exposure to that following sodium Pb acetate or arsenate exposure (Eqs. 1 and 2). All concentrations were based on dry weight (dw).
Pb dose soil × 100%
(1)
As RBA(%) = As concentration soil As concentration sodium arsenate × As dose sodium arsenate As dose soil × 100% (2) where Pb/As concentration soil and Pb/As concentration Pb(Ac) 2 /Na 2 HAsO 4 = Pb/As concentration in mouse kidneys following soil and Pb(Ac) 2 /Na 2 HAsO 4 exposure; Pb/As dose soil and Pb/As dose Pb(AC)2/Na2HAsO4 = Pb/As dose level for mice exposed to soil and Pb(Ac) 2 /Na 2 HAsO 4 .
Pb and As bioaccessibility in contaminated soils
Four in vitro assays including UBM, SBRC, IVG, and PBET were used to assess Pb and As bioaccessibility in P-amended soils. The UBM method consists with 3 phases (saliva, gastric, and intestinal) while the other 3 methods have 2 phases (gastric and intestinal). Detailed procedures, extraction parameters, and fluid compositions are provided in Table S1 [2, 28] . In vitro assays were performed in triplicate. Bioaccessibility was calculated by dividing extractable Pb or As in gastric phase or intestinal phase by total Pb or As in soils.
Statistical analysis
All data are expressed as means and standard deviation of triplicate analysis. SPSS 10.0 was used to perform one-way ANOVA based on least significant test to determine the difference in Pb-or As-RBA or Pb-or As-bioaccessibility between control and P-treated soils. All graphs were drawn using Origin 9.0.
Results and discussion
Lead and As contaminated soils
Five soils were collected from different locations, which were contaminated from mining (soil B), and smelting (soils A, C, D and E) activities (Table 1 ). The total concentrations of As and Pb were 106-833 mg kg −1 and 1543-8123 mg kg −1 in <250 m fraction. Soil properties varied among soils, with pH ranging from 6.54 to 8.96, and TOC 1.26%-4.55%. Clay fractions (2.91-13.4%), total P (211-835 mg kg −1 ), total Ca (6.61-48.1 g kg −1 ) and amorphous Fe (Table 1) .
A newly-developed mouse kidney bioassay based on repeated daily single gavage
In this study, a new dosing approach was developed to measure Pb and As relative bioavailability (RBA) in P-amended soils by repeated daily single dose of soil gavage to fasted mice over a 10-d period. Previous studies reported that liver and kidneys can be used as endpoints for long term steady state exposure for mice [26, 27] . In the current study, kidneys were used as endpoint due its higher Pb and As accumulation than that in liver. Based on exposure dose in contaminated soils, a range of Pb(Ac) 2 (0-1500 mg L −1 ) and Na 2 HAsO 4 (0-200 mg L −1 ) concentrations were used to establish the dose response curve (Fig. 1) . In the control mice, low Pb and As concentrations in kidneys were found (212 and 556 g kg −1 bw). When exposed to Pb(AC) 2 and Na 2 HAsO 4 , Pb and As concentrations in kidneys increased to 9791-53028 g kg −1 bw and 614-3448 g kg −1 bw, showing good linear relationship with exposure does (R 2 = 0.93 and 0.99; Fig. 1 ) and the suitability of the newly-developed dosing approach to determine Pb and As-RBA in P-amended soils.
Currently, area under blood concentration curve (AUC) after a single gavaged dose and steady-state accumulation in the liver or kidneys after multiple doses via diet have been used to determine Pb and As-RBA in contaminated soils [26, 27, 29, 30] . For the blood AUC method, the relative standard deviation (RSD) for RBA is often higher than 20%, a guideline suggested by Wragg et al. [31] . RBA determined via steady state exposure shows lower RSD [26] , but this method is achieved by mixing soil with mouse feed, which is enriched with phosphorus. Therefore, it may not be suitable to study the influence of P amendment on Pb and As-RBA. In contrast, the present method using repeated daily single dose of soil gavage to fasted animal over a 10-d period can overcome these drawbacks, which was used to determine Pb-and As-RBA in PA-amended soils.
P amendment reduced Pb-RBA in soils
Based on the mouse kidneys bioassay following repeated daily single gavaged dose of soil for 10 d, Pb-RBA in soils was determined. In control soils, Pb-RBA varied from 14.2 to 62.5% ( Fig. 2A) . Lead-RBA was higher in soils A and E (55.6-62.5%) and lower in soils B and C (14.2-21.2%). Soil A and E were from farming sites with pH of 8.31 − 8.96, favorable for formation of Pb carbonate, thereby showing higher bioavailability [32] . It has been reported that Pb-RBA in mining-impacted soils is usually lower than that in smelting-impacted soils due to the presence of insoluble Pb minerals such as galena and Pb phosphate [3, 33] . In addition, soil properties also influence Pb-RBA in soils [7] . Amorphous Fe in soil C (15.4 g kg −1 ) was much higher than it in soil B (5.10 g kg −1 ; Table 1 ), possibly contributing its lower Pb-RBA in soil C. This is because, in acidic stomach environment, dissolved Fe may inhibit Pb absorption across the GI barrier via divalent metal transporter [34] whereas in neutral intestinal condition, the dissolved Fe may co-precipitate with Pb, thereby lowing bioavailable Pb [35] .
Compared to control soils, Pb-RBA in PA-amended soils decreased by 0.4-2.0 fold to 10.1-29.8% (Fig. 2A) . To facilitate Pb immobilization in soils, the pH should be below 4 [21] . The pH was 5.3-7.2 in PA-amended soils in this study, which may be unfavorable for pyromorphite formation. Juhasz et al. [3] showed that insoluble Pb-P minerals including pyromorphite and Pb phosphate can form in local areas with low pH in a smelting-impacted soil after amending with PA at pH 6.1 based on X-ray absorption spectroscopy. In addition, pyromorphite can also form in low pH environment in gastrointestinal phase in vivo. They showed significant decrease of Pb-RBA in contaminated soils following a sequential gavage of soil and P using a mouse model, with in vivo formation of pyromorphite being confirmed by X-ray absorption spectroscopy [3] . Several studies also reported effect of phosphate in reducing Pb-RBA in soils. Ryan et al. [23] reported that swine fed soils amended with 0.5-1% PA showed lower blood-Pb levels compared to control swine. Hettiarachchi et al. [36] showed that Pb-RBA was significantly reduced by amending smelting-impacted soils with 5000 mg kg −1 triple superphosphate or rock phosphate based on a rat model. Results in this study are consistent with literature, confirming P amendment is effective in reducing Pb-RBA in soils.
Variable effects of P amendment on As-RBA in soils
Compared to Pb, there is a lack of report regarding the influence of P amendment on As-RBA in soils. In this study, As-RBA in soils was determined using the newly-developed mouse kidney bioassay. In control soils, As-RBA varied from 26.5 to 58.8% (Fig. 2B) , with lowest RBA being in mining-impacted soil B where As was probably present as insoluble scorodite and arsenopyrite [7] . Like Pb, As-RBA in soils A and E (54.8-58.8%) were higher than those of others soils (26.5-35.8%) [7, 37] .
Unlike Pb, the effects of PA amendment on As-RBA in soils were variable. Compared to control soils, As-RBA in soils A, C, and E was not significantly changed (35.8-58.8 to 28.1-61.1%) with P amendment, while As-RBA significantly decreased from 26.5% to 15.9% in soil B but increased from 27.5 to 41.2% in soil D (Fig. 2B) . Correlations between soil properties, bioavailable As (calculated by multiplying As-RBA in control soils with total As concentration) and increased As-RBA (calculated by subtracting As-RBA in treated soils with those in control soils) were performed (Table S2) As-RBA was negatively correlated with P (R = −0.53) and bioavailable As (−0.73). The correlations illustrated that high level of P in soils may not increase As-RBA as expected. In addition, higher bioavailable As did not result in greater increase in As-RBA possibly due to elevated P. Phosphate affected As-RBA in soils probably via the following mechanisms. As an analog, phosphate can desorb As from soils in the gastric phase and inhibit As absorption on newly-formed Fe oxides in the intestinal phase, thereby increasing As-RBA [38, 39] . However, phosphate can inhibit arsenate absorption by P transporter in the intestinal phase, thereby decreasing As-RBA [12] . Though studies show phosphate inhibits As absorption in the intestinal phase [40] , it can also increase bioavailable As in contaminated soils [41] . Therefore, the net effect of P on As-RBA in soils depends on the extent of P-induced As mobilization from soils and P-induced competition for As uptake by mice, leading to variable effects of P on As-RBA in soils.
Effects of P amendment on Pb and As bioaccessibility
To assess Pb-and As-RBA in soils at a large scale, it is important to develop in vitro bioaccessibility assay, which can predict Pb-and As-RBA in P-amended soils. In this study, four common assays including UBM, SBRC, IVG, and PBET were used to assess their suitability to predict Pb-and As-RBA in P-amended soils.
In control soils, Pb bioaccessibility based on the acid gastric phase (pH 1.2-2.5) was the highest in SBRC (17.0-85.8%), followed by UBM (14.3-83.9%), IVG (13.5-72.0%), and PBET (4.55-50.4%) (Fig. 3) . These results were similar to Li et al. [42] who contributed the difference to their pH and soil/solution ratios (Table S1 ). In PAamended soils, Pb bioaccessibility decreased slightly based on UBM (13.4-83.5%) and SBRC (16.8-85.6%) gastric pahse with pH 1.2 and 1.5 (Fig. 3) . With gastric pH increasing to 1.8 and 2.5, decrease in Pb bioaccessibility was more apparent with IVG at 10.9-64.3% and PBET at 3.04-36.5%. The difference among four assays illustrated that gastric pH played an important role in controlling Pb bioaccessibility in soils. In current study, Pb-phosphate minerals were probably not formed due to its unfavorable pH (5.3-7.2) during aging process. However, during gastric phase assay, Pb-phosphate mineral may be formed via dissolution of Pb and phosphate [19, 43] . The stability of formed Pb-phosphate minerals is influenced by solution pH as they may be soluble at pH < 2.12 (pK a1 ) [8, 21] . As such, the decrease in Pb bioaccessibility in PBET gastric phase with P amendment was more significant than other assays (pH 2.5 vs. 1.2-1.8; Table S1 ). Extending in vitro assays from the acid gastric to neutral intestinal phase (5.5-7.0), as expected, Pb bioaccessibility in control soils sharply decreased to 0.08-3.98, 0.28-22.8, 0.40-5.75, and 0.24-9.79% for UBM, SBRC, IVG, and PBET, respectively. This was probably due to Pb resorption on soil matrix and/or Pb coprecipitated with Fe oxides [34, 42, 44] . In addition, P amendment significantly decreased Pb bioaccessibility to 0.03-1.63, 0.07-2.34, 0.15-1.85, and 0.16-2.90%. Formation of Pb-phosphate minerals in neutral intestinal phase may be responsible [21] .
The effect of P amendment on As bioaccessibility was different from that of Pb bioaccessibility. As an analog of As, phosphate can desorb As from soils, increasing As bioaccessibility [39] . Therefore, P amendment increased As bioaccessibility from 8.35-72.2%, 1.40-69.0%, 4.15-50.3%, and 2.32-51.5% in control soils to 7.96-71.3, 8.59-76.1, 5.63-53.7, and 5.32-52.9% in P-amended soils based on gastric phases of UBM, SBRC, IVG, and PBET (Fig. 4) . With P amendment, As bioaccessibility in the gastric phase was higher in UBM, followed by SBRC, IVG, and PBET, following the order of their gastric pH (1.2, 1.5, 1.8 and 2.5) [2, 45] . In the intestinal phase, As bioaccessibility in control soils were unchanged for UBM (7.20-66 .2%) and PBET (1.52-39.2%) but lower in SBRC (0.94-41.4%) and IVG (3.37-53.9%). Similar to the gastric phase, P amendment increased As bioaccessibility to 7.51-63.8, 6.31-59.0, 5.15-57.0, and 5.18-37.8% in the intestinal phase. The data implied that phosphate probably inhibited As absorption on amorphous Fe oxides in intestinal phase [38, 46] . Among different assays, effect of P amendment on As bioaccessibility were less obvious based on UBM than other three assays. This may be due to the different phosphate content used by different assays. In UBM assay, its P concentration in gatrointestinal fluids was 3000 mg L −1 , so P amendment showed little impact on the As bioaccessibility (Table S1 ). In comparison, there was no P in gastrointestinal fluids of other 3 assays.
Comparing effects of P amendment on RBA and bioaccessibility
Compared to control soils, P amendment reduced Pb-RBA by 4.10-32.7% in PA-amended soils (Fig. 2) . Based on the gastric phases of UBM, SBRC, and IVG, the reduction was 0.26-3.60, 0.21-2.90, and 0.88-9.28% (Fig. 3) , which was much less than those based on a mouse model, illustrating underestimation by in vitro assays. However, based on gastric pahse of PBET, the effect (1.51-19.1%) was more comparable with in vivo data. Ryan et al. [23] showed Pb bioaccessibility in soils amended with 1% P decreased from 35% to 10% as SBRC gastric pH increased from 1.5 to 2.5, which is more comparable to Pb-RBA using a swine model. Obrycki et al. [47] used a modified gastric SBRC at pH 2.5 to predict bioavailable Pb in Pamended soils. Henry et al. [8] attributed that solution pH had an effect on phosphate chemistry as well as stability of the formed Pb-phosphate minerals [21] . For better comparison, the gastric pH of UBM, SBRC, and IVG were adjusted to the same at 2.5, the Pb bioaccessibility decreased to 2.98-11.1, 2.31-26.8, and 2.57-23.9% (Fig. 5) , which was more comparable with Pb-RBA decrease based on a mouse model. Based on the intestinal pahse of UBM, SBRC, IVG, and PBET, Pb bioaccessibility decreased to 0.04-2.34, 0.15-20.4, 0.25-3.90, and 2.00-8.05%, with only SBRC being comparable with Pb-RBA (Fig. 3) . Our results suggested the potential of gastric PBET and intestinal SBRC to predict Pb-RBA in PA-amended soils. However, due to limited sample size of 5 soils, further study is needed using large sample size. In addition, our study only considered the influence of PA, which might not be practicable for soil remediation. Inclusion of other phosphate amendment including rock phosphate is necessary for in vitro assay to predict Pb-RBA in P-amended soils.
Unlike Pb, PA amendment significantly increased As bioaccessibility based on UBM and PBET excluding soils A and D showing little change. However, after amended with PA, As-RBA did not change based on in vivo data excluding soil B and D, which had a lower As-RBA. Based on the variable effect of PA on As-RBA and bioaccessibility, the four in vitro methods were unsuitable to predict As-RBA in PA-amended soils. This may be due to the influence of P on As absorption by the same transporter as only the chemical process such as competitive absorption between P and As is considered during in vitro assays [12] . To develop a suitable in vitro assay to predict As-RBA in PA-amended soils, in vitro simulation of As absorption across the GI barrier needs to be considered.
Conclusions
In this study, a newly-developed mouse kidney model and 4 in vitro assays including UBM, SBRC, IVG, and PBET were employed to study the effect of P on Pb and As bioavailability in 5 soils co-contaminated with Pb and As. Based on the mouse model, PA addition significantly decreased Pb-PBA from 14.2-62.5% to 10.1-29.8%. However, its influence on As-RBA depended on soils, with 1 soil decreasing from 26.5% to 15.9%, 1 soil increasing from 27.5 to 41.2% and 3 soils being unchanged (35.8-58.8 to 28.1-61.1%). Based on in vitro assays, Pb bioaccessibility generally decreased from 0.08-85.8% to 0.03-85.6% in PA-amended soils while As bioaccessibility increased from 0.94-72.2% to 5.15-76.1%. When comparing effects of PA amendment on Pb RBA and bioaccessibility, the reduction in Pb-RBA (4.10-32.7%) was comparable with reduced Pb bioaccessibility based on gastric PBET (1.51-19.1%) and intestinal SBRC (0.15-20.4%), illustrating these two methods may have potential to predict the effects of P on Pb-RBA in contaminated soils. For As, its bioaccessibility increased in PA-amended soils, inconsistent with in vivo data, suggesting the unsuitability of in vitro assays to predict As-RBA in P-amended contaminated soils.
